We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies

Featured Speaker: David Miklos, MD, PhD, Chief Clinical Director, Blood and Marrow Transplantation and Cellular Therapy, Cancer Cell Therapy Stanford University

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

CAR-T benefits are T cell dependent

Treatment schema for CAR-T cell therapy

Explore several case studies

Watch the Webinar